Morning mate,
Going by the quarterly PTX-200 is progressing well. The trial has progress to a higher dose level of 45 mg/m2 as reported in April. Given that PTX reported on the dosing levels at 35 mg/m2 back in April I'm going to assume the increased dosing had probably commenced by late April or early May.
The recent quarterly says further updates in relations to ptx-200 in the coming months so I'm assuming the next update will be a lot sooner than December.
"During the quarter Prescient’s targeted therapy studies for PTX-100 and PTX-200 continue to make excellent progress and enrol patients with no safety issues reported by investigators. On 23 April 2021 Prescient reported on the Phase 1b clinical study of PTX-200 and cytarabine in patients with acute myeloid leukemia (AML) has successfully completed the second cohort at 35 mg/m2 under a modified study protocol, with no safety or toxicity issues observed. The study is now progressing through the higher dose level of 45 mg/m2 and Prescient looks forward to providing updates in coming months."
Cheers.
- Forums
- ASX - By Stock
- Ann: PTX-100 trial advances following successful Phase 1b
Morning mate, Going by the quarterly PTX-200 is progressing...
-
- There are more pages in this discussion • 126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.002(5.26%) |
Mkt cap ! $32.21M |
Open | High | Low | Value | Volume |
3.9¢ | 4.2¢ | 3.8¢ | $64.33K | 1.650M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 35499 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25000 | 0.039 |
3 | 172200 | 0.038 |
7 | 529360 | 0.037 |
8 | 688946 | 0.036 |
7 | 571733 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 35499 | 1 |
0.042 | 200000 | 1 |
0.045 | 409634 | 4 |
0.046 | 200000 | 1 |
0.047 | 588389 | 2 |
Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online